Close Menu

Raw Material Buyer/Planner

Organization
LGC Clinical Diagnostics Division
Job Location
37 Birch Street
Milford, MA 01757
United States
Benefits

Our benefits include:Medical/Dental/Vision/401K and much more!

Job Description

Job PurposeThe Raw Material Buyer/Planner will support the procurement and inventory management of raw materials and production related services in accordance with division supply chain optimization and management objectives.  These objectives include but are not limited to risk mitigation, cost savings/containment, optimizing inventory levels, and maintaining quality initiatives. Key Responsibilities

  • Assist in the enhancement, execution, and management a raw material risk management strategy and process that addresses any potential disruption to each of the 3 manufacturing locations within the division. Specific consideration to be given to supply chain and financial risk, product and process quality, and cost savings opportunities.
  • Prioritize and track high risk materials and their potential impact to our business and production operation; Collaborate with internal stakeholders in the development and execution of product strategies.  Communicate progress to management and key stake holders.
  • Identify and mitigate risks related to supply chain disruption and delays, supplier product and / or  manufacturing changes and supplier inability to support current or future demands
  • Analyse raw material consumption across the global supply chain.  Identify areas of risk and cost savings opportunities.   
  • Partner with Research and Development teams and support new product introduction by proactively sourcing multiple supply chain options for new raw materials identified.
  • Actively participate in corporate, global risk management meetings, communicating information and action plans to key stakeholders.
  • Ensure the supplier and material selection process is aligned with the LGC Quality program.  Execute all actions in accordance with established procedures and processes. Recommend improvements to such processes. 
  • Collaborate with key stakeholders to help solve supplier and material related issues (backorders, product quality concerns).  Initiate and document planned/unplanned material deviations, NCMR’s, and supplier CAPA’s as necessary.
  • Support Planning and Operations by ensuring the integrity of MRP, KANBAN and maintaining appropriate inventory levels of raw materials.
  • Utilize business systems (SAP, Sisense, Tableau) to understand data. Research past and expected spend levels to understand and action areas of cost savings opportunities and potential risk.
  • Maintain strong cross functional relationships to bolster communication with internal and external stakeholders
Requirements

Knowledge, Experience and Technical Skills

  • Ability to identify and develop new sources of supply both externally and within the LGC intercompany network
  • Good understanding of the medical device and biotech industry and market; Clinical Diagnostic market experience preferred
  • High level understanding of GMP processes and regulatory requirements
  • Strong negotiating and problem solving skills
  • Strong business acumen to include presentation skills.
  • Must be able to manage multiple large value purchase orders from negotiation through delivery.
  • Results orientated with strong sense of urgency to mitigate risk and close issues
  • Knowledge of SAP Purchasing Modules with skills and proficiency to include MRP and ability to download and analyse data.
  • Experience writing material and purchasing specifications
  • Experience with quality management systems; ETQ Reliance system experience preferred
  • Advance Excel skills witch include proficiency with Excel formulas, Vlookups and pivot tables
  • Ability to multitask.

Education and/or Experience

  • Minimum of a Bachelor degree in Business and 5 + years supply chain experience in an ISO, cGMP medical device or biotech manufacturing environment.
  • CPM, CPP and / or APICS certification preferred
How to Apply
About Our Organization

LGC’s Clinical Diagnostics Division develops and manufactures a comprehensive portfolio of catalogue and custom-developed diagnostic quality solutions and component materials for the extended life sciences industry. We partner with IVD assay developers, and pharmaceutical, CRO and academic institutions in commercialization activities across the entire diagnostic pipeline - from concept and early stage research, through expedited product development and onwards into routine clinical use. Laboratorians and diagnostic professionals across disciplines of clinical chemistry, immunochemistry, serology, molecular diagnostics and clinical genomics rely on LGC’s products to support accurate and reliable diagnostic results. Our operating entities include SeraCare Life Sciences and Maine Standards Company, which are in vitro diagnostics (IVD) manufacturers of quality measurement tools (calibrators, controls, linearity, EQA/PT, biological materials) and the Native Antigen Company, which is a manufacturer and supplier of viral antigens. Our 300+ employees operate FDA-registered and ISO 13485-accredited facilities in Maine, Massachusetts and Maryland, USA, and an ISO 9001-accredited facility in Oxford, UK.   Each day, our world-class staff, scientific expertise, operational efficiency and superior quality systems are ready to support the range of advanced technologies that collectively improve patient outcomes - from the widely adopted and established through to cutting-edge NGS and precision diagnostics.

A new report finds that women, especially women of color, are missing among the high-earners at research universities in the US, the Chronicle of Higher Education writes. 

Researcher-parents, especially mothers of small children, have lost research time during the COVID-19 pandemic, according to the Chronicle of Higher Education.

Inside Higher Ed reports that the preprint site medRxiv has taken off with the COVID-19 pandemic.

Inside Higher Ed reports some university professors are pushing back against plans for increased numbers of in-person classes for next semester.